Cargando…

Complications of Diabetes 2017

Detalles Bibliográficos
Autores principales:	Papatheodorou, Konstantinos, Banach, Maciej, Bekiari, Eleni, Rizzo, Manfredi, Edmonds, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866895/ https://www.ncbi.nlm.nih.gov/pubmed/29713648 http://dx.doi.org/10.1155/2018/3086167

Ejemplares similares

Complications of Diabetes
por: Papatheodorou, Konstantinos, et al.
Publicado: (2015)

Complications of Diabetes 2016
por: Papatheodorou, Konstantinos, et al.
Publicado: (2016)

The effects of statins on blood pressure: current knowledge and future perspectives
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Statin treatment in the elderly: how much do we know?
por: Rizzo, Manfredi, et al.
Publicado: (2013)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications 2017
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2017)

Management of type 2 diabetes in the new era
por: Liakos, Aris, et al.
Publicado: (2023)

Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues
por: Rizvi, Ali A., et al.
Publicado: (2021)

Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy
por: Karagiannis, Thomas, et al.
Publicado: (2017)

Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
por: Banach, Maciej
Publicado: (2016)

Statin Intolerance—We Know Everything, We Know Nothing
por: Banach, Maciej
Publicado: (2022)

Lipoprotein(a): the enemy that we still don’t know how to defeat
por: Banach, Maciej
Publicado: (2023)

Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?
por: Mitrovic, Bojan, et al.
Publicado: (2022)

Molecular Endocrinology and Metabolism in 2021: What’s New
por: Rizzo, Manfredi
Publicado: (2021)

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
por: Avgerinos, Ioannis, et al.
Publicado: (2019)

Dietary salt intake and atherosclerosis: an area not fully explored
por: Banach, Maciej, et al.
Publicado: (2023)

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
por: Bekiari, Eleni, et al.
Publicado: (2018)

Discussion around statin discontinuation in older adults and patients with wasting diseases
por: Banach, Maciej, et al.
Publicado: (2016)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

Obesity-Related Metabolic Syndrome and Vascular Complications
por: Tesauro, Manfredi, et al.
Publicado: (2013)

Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)
por: Banach, Maciej, et al.
Publicado: (2022)

The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review
por: Maierean, Serban, et al.
Publicado: (2017)

Nutrition, Nutraceuticals and Bioactive Compounds in the Prevention and Fight against Inflammation
por: Surma, Stanisław, et al.
Publicado: (2023)

Diabetic Microvascular Complications
por: Migdalis, I., et al.
Publicado: (2018)

Cardiac Complications of Diabetes
por: Abi Khalil, Charbel, et al.
Publicado: (2018)

CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities
por: Walker, Harry E., et al.
Publicado: (2021)

Interventions Change Soil Functions and the Mechanisms Controlling the Structure of Soil Microbial Communities
por: Papatheodorou, Effimia M.
Publicado: (2023)

Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review
por: Gigi, Eleni, et al.
Publicado: (2018)

Glucose Metabolism Disorders: Challenges and Opportunities for Diagnosis and Treatment
por: Vekic, Jelena, et al.
Publicado: (2022)

Chronic Vascular Complications in Diabetes
por: Jia, Weiping, et al.
Publicado: (2013)

The Bittersweet Beat: Diabetes Complications
por: Rossell, Joana, et al.
Publicado: (2023)

The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2013)

Recent therapeutic targets for the prevention and management of diabetic complications
por: Islam, Md Shahidul, et al.
Publicado: (2023)

Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies
por: Rizvi, Ali Abbas, et al.
Publicado: (2021)

Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022)

JAK Inhibition in Patients with Rheumatoid Arthritis: Haemodynamic Effects and Impact on Micro- and Macrovascular Function. Study Design and Rationale
por: Anyfanti, Panagiota, et al.
Publicado: (2022)

Socioeconomic aspects of incretin-based therapy
por: Karagiannis, Thomas, et al.
Publicado: (2023)

Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2023)

Oxidative Stress and Inflammation in Diabetic Complications
por: Vikram, Ajit, et al.
Publicado: (2014)

Portending Complications in Pediatric Diabetic Ketoacidosis
por: Williams, Vijai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u2vekpsmcef7nhba4q8e9uaqk2